A Study of Baricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
Clinical trial NCT03773978 · COMPLETED
Trial details
- NCT number
- NCT03773978
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-17
- Primary completion
- 2022-01-26
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.